Position
Fidelity in Aktis Oncology, Inc.
Back to the book · All holders of AKTS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $4.1M$17.89 → $32.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q1 2026 | 386.4K | $6.91M | — | — | — | 0.0% |
| Q2 2026 | 285.6K | $9.21M | $32.23 | $4.1M | −$1.8M | 0.0% |